$EL (-3,12%) | Estée Lauder Q1 Earnings Highlights:

🔹 Adjusted EPS: $0.14 (Est. $0.09) 🟢

🔹 Revenue: $3.36B (Est. $3.37B) 🔴; DOWN -4% YoY

🔹 FY25 Guidance Withdrawn due to uncertainty in China and Asia travel retail recovery 😕

🔹 CUTS Dividend by 47% 😕

Q2 Guidance:

🔹 Adjusted EPS: $0.20 - $0.35 (Est. $1.09) 🔴; expected decrease of 77% to 60% YoY

🔹 Revenue Decline: Projected DOWN -8% to -6% YoY

Segment Performance:

Skin Care

🔹 Revenue: $1.53B; DOWN -8% YoY

🔹 Growth in EMEA and The Americas, led by Advanced Night Repair and Revitalizing Supreme+

🔹 Declines driven by La Mer and Estée Lauder in China and Asia travel retail due to lower consumer sentiment

Makeup

🔹 Revenue: $1.04B; DOWN -2% YoY

🔹 Declines led by M·A·C (North America softness) and Too Faced

🔹 Clinique up double digits, fueled by strong lip product performance and Amazon launch

Fragrance

🔹 Revenue: $630M; DOWN -1% YoY

🔹 Growth in EMEA and Asia/Pacific, driven by Le Labo and new BALMAIN Beauty launch

🔹 TOM FORD and Jo Malone London flat due to travel retail challenges

Hair Care

🔹 Revenue: $139M; DOWN -6% YoY

🔹 Driven by Aveda, reflecting shipment timing and North America salon softness

Regional Performance:

The Americas

🔹 Revenue: $1.19B; DOWN -1% YoY

🔹 Growth in Latin America, offset by softness in North America (M·A·C, Aveda)

Europe, Middle East & Africa (EMEA)

🔹 Revenue: $1.23B; DOWN -4% YoY

🔹 Decline led by Asia travel retail pressures and market deceleration

🔹 Gains in online and direct-to-consumer channels

Asia/Pacific

🔹 Revenue: $944M; DOWN -11% YoY

🔹 Double-digit growth in Japan, offset by softness in mainland China and Hong Kong SAR

Dividend Update:

🔹 Quarterly Dividend: $0.35/share, reduced by 47% from $0.66

🔹 Payable December 16, 2024, to shareholders as of November 29, 2024